nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cabozantinib exposure–response analyses of efficacy and safety in patients with advanced hepatocellular carcinoma
|
Nguyen, Linh |
|
|
46 |
6 |
p. 577-589 |
artikel |
2 |
Cardiac risk assessment based on early Phase I data and PK-QTc analysis is concordant with the outcome of thorough QTc trials: an assessment based on eleven drug candidates
|
Gaitonde, Puneet |
|
|
46 |
6 |
p. 617-626 |
artikel |
3 |
Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes
|
German, Carrie |
|
|
46 |
6 |
p. 513-529 |
artikel |
4 |
Concentration–response modeling of ECG data from early-phase clinical studies to assess QT prolongation risk of contezolid (MRX-I), an oxazolidinone antibacterial agent
|
Wu, Junzhen |
|
|
46 |
6 |
p. 531-541 |
artikel |
5 |
Correction to: Bayesian approach to investigate a two-state mixed model of COPD exacerbations
|
Largajolli, Anna |
|
|
46 |
6 |
p. 627 |
artikel |
6 |
Handling underlying discrete variables with bivariate mixed hidden Markov models in NONMEM
|
Brekkan, A. |
|
|
46 |
6 |
p. 591-604 |
artikel |
7 |
Impact of Phase 1 study design on estimation of QT interval prolongation risk using exposure–response analysis
|
Tsamandouras, Nikolaos |
|
|
46 |
6 |
p. 605-616 |
artikel |
8 |
Journal editor’s final report
|
Jusko, William J. |
|
|
46 |
6 |
p. 511-512 |
artikel |
9 |
Mathematical modeling of the glucagon challenge test
|
Masroor, Saeed |
|
|
46 |
6 |
p. 553-564 |
artikel |
10 |
Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis
|
Alhadab, Ali A. |
|
|
46 |
6 |
p. 565-576 |
artikel |
11 |
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients
|
Berends, Sophie E. |
|
|
46 |
6 |
p. 543-551 |
artikel |